Incidence and Predictors of an Abnormal Liver Function Test Among 674 Systemic Sclerosis Patients: A Cohort Study
Kookwan Sawadpanich,1 Palinee Promasen,1 Pisaln Mairiang,1 Wattana Sukeepaisarnjareon,1 Apichat Sangchan,1 Tanita Suttichaimongkol,1 Kawin Tangvoraphonkchai,1 Chingching Foocharoen2 1Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2023-05-01
|
| Series: | Open Access Rheumatology: Research and Reviews |
| Subjects: | |
| Online Access: | https://www.dovepress.com/incidence-and-predictors-of-an-abnormal-liver-function-test-among-674--peer-reviewed-fulltext-article-OARRR |
| _version_ | 1797825917428432896 |
|---|---|
| author | Sawadpanich K Promasen P Mairiang P Sukeepaisarnjareon W Sangchan A Suttichaimongkol T Tangvoraphonkchai K Foocharoen C |
| author_facet | Sawadpanich K Promasen P Mairiang P Sukeepaisarnjareon W Sangchan A Suttichaimongkol T Tangvoraphonkchai K Foocharoen C |
| author_sort | Sawadpanich K |
| collection | DOAJ |
| description | Kookwan Sawadpanich,1 Palinee Promasen,1 Pisaln Mairiang,1 Wattana Sukeepaisarnjareon,1 Apichat Sangchan,1 Tanita Suttichaimongkol,1 Kawin Tangvoraphonkchai,1 Chingching Foocharoen2 1Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, 40002, Thailand; 2Division of Rheumatology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, 40002, ThailandCorrespondence: Chingching Foocharoen, Division of Rheumatology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, 40002, Thailand, Tel +66-43-363-746 ; +66-43-363-664, Email fching@kku.ac.thBackground: Abnormal liver function tests (LFTs) can indicate cirrhosis or liver cancer leading to mortality among systemic sclerosis (SSc) patients. No recent studies have investigated the clinical predictors of an abnormal LFT in SSc. We aimed to determine the incidence of abnormal LFT (including from hepatitis and cholestasis) and to identify its clinical predictors in SSc patients.Methods: An historical cohort was conducted on 674 adult SSc patients who attended the Scleroderma Clinic, Khon Kaen University, between January 2012 and November 2019 and who underwent routine screening for LFT. A Cox regression was used to analyze the clinical predictors of abnormal LFT.Results: Four hundred and thirty cases, representing 4190 person-years, had abnormal LFTs (viz, from hepatitis, cholestasis, and cholestatic hepatitis) for an incidence rate of 10.2 per 100 person-years. The respective incidence of hepatitis, cholestasis, and cholestatic hepatitis was 20.5, 12.9, and 20.4 per 100 person-years. The respective median first-time detection of hepatitis, cholestasis, and cholestatic hepatitis was 3.0, 5.9, and 2.8 years, and none had signs or symptoms suggestive of liver disease. According to the Cox regression analysis, the predictors of an abnormal LFT in SSc were elderly onset of SSc (hazard ratio (HR) 1.02), alcoholic drinking (HR 1.74), high modified Rodnan Skin Score (mRSS) (HR 1.03), edematous skin (HR 2.94), Raynaud’s phenomenon (HR 1.39), hyperCKaemia (HR 1.88), and methotrexate use (HR 1.55). In contrast, current sildenafil treatment (HR 0.63) and high serum albumin (HR 0.70) were protective factors.Conclusion: Occult hepatitis, cholestasis, and cholestatic hepatitis can be detected in SSc patients using LFT screening, especially in cases of early disease onset. The long-term outcome is uncertain, and more longitudinal research is required.Keywords: systemic sclerosis, scleroderma, scleroderma and related disorders, hepatitis, cholestasis, cholestatic hepatitis, abnormal liver function test, liver, cohort study |
| first_indexed | 2024-03-13T11:00:57Z |
| format | Article |
| id | doaj.art-f58f3e9bd67e4b4a85a428d320a1432f |
| institution | Directory Open Access Journal |
| issn | 1179-156X |
| language | English |
| last_indexed | 2024-03-13T11:00:57Z |
| publishDate | 2023-05-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Open Access Rheumatology: Research and Reviews |
| spelling | doaj.art-f58f3e9bd67e4b4a85a428d320a1432f2023-05-16T19:06:18ZengDove Medical PressOpen Access Rheumatology: Research and Reviews1179-156X2023-05-01Volume 15819283762Incidence and Predictors of an Abnormal Liver Function Test Among 674 Systemic Sclerosis Patients: A Cohort StudySawadpanich KPromasen PMairiang PSukeepaisarnjareon WSangchan ASuttichaimongkol TTangvoraphonkchai KFoocharoen CKookwan Sawadpanich,1 Palinee Promasen,1 Pisaln Mairiang,1 Wattana Sukeepaisarnjareon,1 Apichat Sangchan,1 Tanita Suttichaimongkol,1 Kawin Tangvoraphonkchai,1 Chingching Foocharoen2 1Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, 40002, Thailand; 2Division of Rheumatology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, 40002, ThailandCorrespondence: Chingching Foocharoen, Division of Rheumatology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, 40002, Thailand, Tel +66-43-363-746 ; +66-43-363-664, Email fching@kku.ac.thBackground: Abnormal liver function tests (LFTs) can indicate cirrhosis or liver cancer leading to mortality among systemic sclerosis (SSc) patients. No recent studies have investigated the clinical predictors of an abnormal LFT in SSc. We aimed to determine the incidence of abnormal LFT (including from hepatitis and cholestasis) and to identify its clinical predictors in SSc patients.Methods: An historical cohort was conducted on 674 adult SSc patients who attended the Scleroderma Clinic, Khon Kaen University, between January 2012 and November 2019 and who underwent routine screening for LFT. A Cox regression was used to analyze the clinical predictors of abnormal LFT.Results: Four hundred and thirty cases, representing 4190 person-years, had abnormal LFTs (viz, from hepatitis, cholestasis, and cholestatic hepatitis) for an incidence rate of 10.2 per 100 person-years. The respective incidence of hepatitis, cholestasis, and cholestatic hepatitis was 20.5, 12.9, and 20.4 per 100 person-years. The respective median first-time detection of hepatitis, cholestasis, and cholestatic hepatitis was 3.0, 5.9, and 2.8 years, and none had signs or symptoms suggestive of liver disease. According to the Cox regression analysis, the predictors of an abnormal LFT in SSc were elderly onset of SSc (hazard ratio (HR) 1.02), alcoholic drinking (HR 1.74), high modified Rodnan Skin Score (mRSS) (HR 1.03), edematous skin (HR 2.94), Raynaud’s phenomenon (HR 1.39), hyperCKaemia (HR 1.88), and methotrexate use (HR 1.55). In contrast, current sildenafil treatment (HR 0.63) and high serum albumin (HR 0.70) were protective factors.Conclusion: Occult hepatitis, cholestasis, and cholestatic hepatitis can be detected in SSc patients using LFT screening, especially in cases of early disease onset. The long-term outcome is uncertain, and more longitudinal research is required.Keywords: systemic sclerosis, scleroderma, scleroderma and related disorders, hepatitis, cholestasis, cholestatic hepatitis, abnormal liver function test, liver, cohort studyhttps://www.dovepress.com/incidence-and-predictors-of-an-abnormal-liver-function-test-among-674--peer-reviewed-fulltext-article-OARRRsystemic sclerosissclerodermascleroderma and related disordershepatitischolestasischolestatic hepatitisabnormal liver function testlivercohort study |
| spellingShingle | Sawadpanich K Promasen P Mairiang P Sukeepaisarnjareon W Sangchan A Suttichaimongkol T Tangvoraphonkchai K Foocharoen C Incidence and Predictors of an Abnormal Liver Function Test Among 674 Systemic Sclerosis Patients: A Cohort Study Open Access Rheumatology: Research and Reviews systemic sclerosis scleroderma scleroderma and related disorders hepatitis cholestasis cholestatic hepatitis abnormal liver function test liver cohort study |
| title | Incidence and Predictors of an Abnormal Liver Function Test Among 674 Systemic Sclerosis Patients: A Cohort Study |
| title_full | Incidence and Predictors of an Abnormal Liver Function Test Among 674 Systemic Sclerosis Patients: A Cohort Study |
| title_fullStr | Incidence and Predictors of an Abnormal Liver Function Test Among 674 Systemic Sclerosis Patients: A Cohort Study |
| title_full_unstemmed | Incidence and Predictors of an Abnormal Liver Function Test Among 674 Systemic Sclerosis Patients: A Cohort Study |
| title_short | Incidence and Predictors of an Abnormal Liver Function Test Among 674 Systemic Sclerosis Patients: A Cohort Study |
| title_sort | incidence and predictors of an abnormal liver function test among 674 systemic sclerosis patients a cohort study |
| topic | systemic sclerosis scleroderma scleroderma and related disorders hepatitis cholestasis cholestatic hepatitis abnormal liver function test liver cohort study |
| url | https://www.dovepress.com/incidence-and-predictors-of-an-abnormal-liver-function-test-among-674--peer-reviewed-fulltext-article-OARRR |
| work_keys_str_mv | AT sawadpanichk incidenceandpredictorsofanabnormalliverfunctiontestamong674systemicsclerosispatientsacohortstudy AT promasenp incidenceandpredictorsofanabnormalliverfunctiontestamong674systemicsclerosispatientsacohortstudy AT mairiangp incidenceandpredictorsofanabnormalliverfunctiontestamong674systemicsclerosispatientsacohortstudy AT sukeepaisarnjareonw incidenceandpredictorsofanabnormalliverfunctiontestamong674systemicsclerosispatientsacohortstudy AT sangchana incidenceandpredictorsofanabnormalliverfunctiontestamong674systemicsclerosispatientsacohortstudy AT suttichaimongkolt incidenceandpredictorsofanabnormalliverfunctiontestamong674systemicsclerosispatientsacohortstudy AT tangvoraphonkchaik incidenceandpredictorsofanabnormalliverfunctiontestamong674systemicsclerosispatientsacohortstudy AT foocharoenc incidenceandpredictorsofanabnormalliverfunctiontestamong674systemicsclerosispatientsacohortstudy |